Mammalian development requires effective mechanisms to repress genes whose expression 19 would generate inappropriately specified cells. The Polycomb Repressive Complex 1 (PRC1) 20 family complexes are central to maintaining this repression 1 . These include a set of canonical 21 PRC1 complexes that each contain four core proteins, including one from the CBX family. These 22 complexes have previously been shown to reside in membraneless organelles called Polycomb 23
bodies, leading to speculation that canonical PRC1 might be found in a separate phase from the 24 rest of the nucleus 2,3 . We show here that reconstituted PRC1 readily phase separates into droplets 25 in vitro at low concentrations and physiological salt conditions. This behavior is driven by the 26 CBX2 subunit. Point mutations in an internal domain of CBX2 eliminate phase separation. These 27 same point mutations eliminate the formation of puncta in cells, and have previously been shown 28 to eliminate nucleosome compaction in vitro 4 and to generate axial patterning defects in mice 5 . 29
Thus, a single domain in CBX2 is required for phase separation and nucleosome compaction, a 30 finding that relates these functions to each other and to proper development. 31 32
Main Text 33
Proper organismal development requires precise regulation of gene expression that is 34 stably maintained. Polycomb-Group (PcG) repressive complexes PRC1 and PRC2 directly act on 35 chromatin to repress key developmental genes and maintain this repressed state throughout 36 development. PRC2 complexes trimethylate lysine 27 on histone H3 (H3K27me3) and this 37 modification recruits canonical PRC1 complexes ( Fig. 1a) 1 . Canonical PRC1 complexes contain 38 a CBX protein, which binds to the H3K27me3 mark via a chromodomain at the N-terminus and 39 interacts with RING1b, a key PRC1 protein, via a C-Box at the C-terminus. CBX2, the focus of 40 this study, also contains a positively charged low-complexity disordered region (LCDR). 41
Mutations in this region that reduce the overall positive charge disrupt chromatin compaction in 42 vitro and result in axial patterning defects in the mouse 4,5 . 43
Compaction of chromatin restricts the movement of nucleosomes and makes them less 44 accessible to transcriptional activators. The resulting repressive chromatin state might be further 45 accentuated by compartmentalizing compacted chromatin. Phase separation has been proposed as a mechanism to accomplish this in heterochromatin, based upon the finding that a central component of heterochromatin, HP1a/α, phase separates 6,7 . PRC1 is concentrated into nuclear 48 foci called Polycomb bodies 2,3 , one of several classes of 'membraneless organelles' that are 49 believed to form by phase separation to enrich and sequester components from bulk solution. 50
Thus, PRC1 can form phase-separated condensates in vitro and CBX2 is a candidate to drive this 70 phase separation. 71
We examined CBX2 mutants to identify a region needed for phase separation. CBX2 72 contains a positively charged LCDR (Extended Data Fig. 3a, b ), a type of domain often found in 73 proteins that phase separate 11 . This LCDR was previously shown to be critical for the ability of 74 CBX2 to compact nucleosomal arrays in vitro 4 and regulate proper murine development 5 . A 75 paralogous subunit, CBX7, which lacks the ability to compact nucleosomal arrays in vitro 4 , does 76 not have a positively charged LCDR. To test the importance of the CBX2 LCDR for phase 77 separation in vitro, we purified mEGFP-tagged variants of CBX2 in combination with RING1b 78 that reduce (CBX2-23KRA) or increase (CBX2-DEA) the net positive charge of the region, as 79 well as a heterodimer of mEGFP-CBX7 and RING1b ( Fig. 2a and Extended Data Fig. 3c ). In 80 contrast to wild-type CBX2, both mEGFP-CBX2-23KRA + RING1b and mEGFP-CBX7 + 81
RING1b failed to form a protein-rich pellet after centrifugation, while mEGFP-CBX2-DEA + 82
RING1b retained the ability to separate from bulk solution (Fig. 2b ). In agreement with these 83 data, fluorescence microscopy revealed condensates formed by mEGFP-CBX2 + RING1b and 84 mEGFP-CBX2-DEA + RING1b, whereas mEGFP-CBX2-23KRA + RING1b and mEGFP-85 CBX7 + RING1b remained diffuse ( Fig. 2c and Extended Data Fig. 2 ). In addition, PRC1 86 containing mEGFP-CBX2-23KRA showed impaired phase separation relative to PRC1 87 containing wild-type CBX2, indicating that the LCDR of CBX2 is a driving force for PRC1 88 phase separation (Fig. 2b, c ). Finally, a CBX2 mutation, disrupting only 13 rather than 23 89 positively charged residues, CBX2-13KRA, also known to impair nucleosome compaction in 90 vitro and axial development in mice, failed to phase separate in vitro (Extended Data Fig. 4a ). 91
We conclude the positive charge within the CBX2 LCDR is critical for phase separation in vitro, 92 in addition to its previously described roles in chromatin compaction 4 and proper axial patterning 93 in mice 5 . 94
The observation that mutations in positively charged residues disrupt phase separation 95 raised the hypothesis that negatively charged residues in CBX2 might form multivalent 96 interactions with the positive residues. Mutation of negative residues within the LCDR (CBX2-97 DEA) did not impact phase separation, leading us to consider other sources of negative charge. 98
Phosphorylation increases negative charge and modulates phase separation of proteins both 99 positively and negatively 6,7,12-15 . Serine residues in CBX2 are phosphorylated in vivo and 100 targeted by casein kinase II (CK2) in vitro 16 . We tested a role for phosphorylation in condensate 101 formation by using E.coli to express a truncated, non-phosphorylated, form of CBX2 (mEGFP-102 CBX2DCbox) stable in the absence of RING1b. We also co-expressed this protein with the 103 catalytic subunits of CK2 to generate phosphorylated mEGFP-CBX2DCbox. Phosphorylation 104 was validated by mass spectrometry (Extended Data Fig. 5 , Supplementary Table 1) . 105
Phosphorylated mEGFP-CBX2DCbox formed spherical droplets, distinct in size and shape from 106 the more diffuse signal and small non-spherical aggregates formed by unphosphorylated 107 mEGFP-CBX2DCbox ( Fig. 2d ). Thus, phosphorylation of CBX2 increases the ability of CBX2 108 to phase separate, suggesting a role for electrostatic interactions within CBX2 in driving 109 condensate formation. 110
To determine whether the droplets formed by mEGFP-CBX2DCbox were solid 111 aggregates or reversible liquid condensates, we performed a salt-dependent reversibility assay. 112
Droplets were formed and visualized as described above (Fig. 2d, e ) and the salt concentration 113 was then increased to 500 mM KCl. At higher salt, the preformed droplets drastically reduced in 114 number and size ( Fig. 2e ). Reducing the salt concentration to 100 mM KCl resulted in 115 reformation of droplets, albeit smaller due to reduced protein concentration ( Fig. 2e ). These 116 results support the hypothesis that reversible electrostatic interactions between phosphorylated 117 serines and positively charged residues are necessary for phase separation of CBX2 in vitro. 118
As mutations in the CBX2 LCDR impair its ability to phase separate in vitro, we assessed 119 the impact of these mutations on the morphology of structures formed by PRC1 in vivo. We 120 expressed different mEGFP-CBX2 variants under a doxycycline-inducible promoter in 3T3 121 fibroblasts. Induction of mEGFP expression produced diffuse signal throughout the nucleus and 122 cytoplasm ( Fig. 3a, b ). In contrast, mEGFP-CBX2 formed nuclear puncta, similar to those 123 previously observed for PRC1 in other cell types 2,3,17,18 . mEGFP-CBX2-KRA mutants failed to 124 form nuclear puncta, while the mEGFP-CBX2-DEA mutant formed puncta similar to those seen 125 for wild-type CBX2 ( 13KRA mirrors the less severe defects in chromatin compaction activity in vitro and in vivo axial 131 patterning phenotype for this mutant relative to CBX2-23KRA. To address whether these puncta 132 contain canonical PRC1 subunits, we used co-immunoprecipitation. This showed that both 133 mEGFP-CBX2 and mEGFP-CBX2-23KRA interacted with other PRC1 subunits in vivo 134 (Extended Data Fig. 7a , Supplementary Table 2 ). Co-immunofluorescence of RING1b revealed 135 extensive co-localization with mEGFP-CBX2 (Extended Data Fig. 7b ) in 3T3 fibroblasts, which 136 do not endogenously express CBX2 (Extended Data Fig. 7c ). Thus, the puncta visualized by 137 mEGFP-CBX2 contained PRC1. These in vivo results recapitulate the findings of our in vitro 138 assays and underscore the importance of positively charged residues in the CBX2 LCDR for 139 PRC1 phase separation. 140
Phase-separated condensates undergoing demixing with the surrounding aqueous 141 environment display a rapid exchange of interacting components 19 . To interrogate the dynamics 142 of nuclear puncta formed by CBX2 in vivo, we performed live cell microscopy of 3T3 fibroblasts 143 expressing mEGFP-CBX2 and mEGFP-CBX2-23KRA ( Figure 3d and Extended Data Fig. 8 ). As 144 seen in formaldehyde-fixed cells, mEGFP-CBX2 organized into puncta whereas mEGFP-CBX2-145 23KRA remained diffusely distributed throughout the nucleus. To examine whether mEGFP-146 CBX2 puncta behave as liquid-like condensates, we performed fluorescence recovery after 147 photobleaching (FRAP). Upon photobleaching, mEGFP-CBX2 puncta rapidly recover 148 fluorescence within 60 seconds ( Fig. 3e , f). Consistent with these nuclear puncta behaving as 149 phase separated condensates, we observed a rapid loss of puncta upon addition of 1,6-150 hexanediol, as observed for other phase separated bodies (Extended Data Fig. 9 ) 7,12,20-22 . We 151 conclude that CBX2 within puncta can readily exchange with free CBX2 in the surrounding 152 environment, consistent with the properties of a liquid-like condensate. 153
Phase separation can facilitate inclusion or exclusion of macromolecules from the 154 protein-dense phase, creating a mechanism to compartmentalize biochemical activities 11 . We 155 tested whether ligands of PRC1, including DNA, RNA, and nucleosomal arrays, could 156 incorporate into PRC1 condensates in vitro. We generated polynucleosomal templates using 157 Cy5-labeled G5E4 DNA 23 , either with heterogeneously modified polynucleosomes or with 158 polynucleosomes containing an H3K27me3 analog 24 . We also included Cy5-labeled G5E4 DNA 159 alone, as well as Cy5-labeled CAT7 RNA previously shown to associate with PRC1 25 . We 160 monitored incorporation of these ligands into PRC1 condensates using fluorescence microscopy.
All four ligands were incorporated into condensates formed by mEGFP-CBX2 + RING1b (Fig.  162 4a) and mEGFP-PRC1 ( Fig. 4b ), whereas free Cy5 dye was not found within the condensate 163 phase. Ligands incorporated into PRC1 condensates regardless of whether they were added to 164 preformed droplets (Extended Data Fig. 10 ) or included during droplet formation ( Fig. 4a ). Thus, 165 PRC1 condensates partition with physiologically relevant ligands, suggesting a mechanism to 166 compartmentalize these interactions in vivo. 167
The bacterially produced unphosphorylated mEGFP-CBX2DCbox did not phase separate 168 by itself ( Fig. 2d ) but can compact nucleosomal templates 4 , indicating a possible difference 169 between these activities. We tested the ability of this protein to phase separate under conditions 170 where compaction can occur, which requires the presence of nucleosomal arrays. Nucleosomal 171 arrays might increase the effective local concentration of this protein, and thus might enhance 172 interactions required for phase separation. Incubating unphosphorylated mEGFP-CBX2DCbox 173 with nucleosomal arrays resulted in condensate formation ( Fig. 4c, d ). Furthermore, we observed 174 that nucleosome arrays containing an H3K27me3 analog, which bind with higher affinity to the 175 CBX2 protein 26 , were more proficient at inducing condensate formation at lower protein 176 concentration. This result is consistent with the hypothesis that phase separation requires a high 177 local concentration of CBX2 protein that can be driven by phosphorylation to increase 178 electrostatic interactions, or to a lesser extent by the addition of nucleosomal arrays to provide a 179 scaffold to facilitate CBX2 interactions. 180
We show that the abilities of PRC1 to phase separate and to compact nucleosomes both 181 require the LCDR of CBX2 and are inhibited by mutation of basic residues. As this domain lies 182 downstream of the chromodomain that binds H3K27me3, several Polycomb-Group functions are 183 combined into a single protein. A simple hypothesis is that nucleosome compaction and phase 184 separation are manifestations of the same phenomenon, and that compacted and phase separated 185
H3K27me3 nucleosomes are separated from the rest of the nucleus. It has previously been shown 186 that the Polyhomeotic (PH) subunit of PRC1 mediates subnuclear clustering through 187 polymerization of its SAM domain [27] [28] [29] . We cannot rule out the possibility that PHC1/2 188 contribute to PRC1 phase separation as only mutants defective in polymerization were tested 189 here for technical reasons. Notably, PHC1 contains an LCDR rich in glutamine residues, which 190 are highly represented in the LCDRs of other proteins that phase separate 30 . Altogether, we 191 propose a model whereby PRC1 compacts nucleosomes and organizes them into phase separated 192 subnuclear condensates in a concerted manner to efficiently and stably repress transcription ( Phosphorylated mEGFP-CBX2DCbox was obtained by co-expression with the catalytic subunits 245 of CKII in a pRSF-Duet vector. Cells were grown to an OD 0.6 at 37°C in 2-YT with 50 µg/mL 246 carbenicillin and 25 µg/mL chloramphenicol. For co-expression with pRSF-Duet CKII vector, 25 247 µg/mL kanamycin was added. Cells were induced with 0.5 mM isopropyl β-D-1-248 thiogalactopyranoside overnight at 18°C. Cell extracts were prepared as previously described 4 . 249
Briefly, harvested cells were resuspended in lysis buffer (50 mM HEPES at pH 7.5, 0.5 mM 250 EDTA, 1.6 M KCl, 20% glycerol, 0.5 mM MgCl 2 , 0.05% NP-40, 1 mg/mL lysozyme, 1 mM 251 DTT, protease inhibitors). The cells were taken through three freeze-thaw cycles, then sonicated 252 to shear DNA before centrifugation at 25,000g for 20 minutes to remove debris. Five percent 253 polyethelenimine (PEI) in 20 mM HEPES pH 7.5 was added dropwise to the supernatant while 254 stirring to a final concentration of 0.15%, and stirred an additional 30 minutes. The precipitated 255 nucleic acid was removed by centrifugation at 25,000g for 20 minutes. Extracts were bound to 256 M2 resin and protein purification was carried out as described for Sf9 cells. Transduced 3T3 fibroblasts containing mEGFP, mEGFP-CBX2 or mEGFP-CBX2-23KRA were 326 grown to 80% confluency in 15 cm tissue culture dishes. Media containing 500 ng/mL of 327 doxycycline was added for 24 hours. Cells were washed with PBS and collected using a cell 328 scraper. Nuclear extracts were prepared as previously described 32 . Protein levels in nuclear 329 extracts were measured on a Nanodrop using A280. Equal protein mass between samples was 330 used in subsequent co-immunoprecipitation (co-IP). 1% volume was saved as input. For co-IP, 331 magnetic protein A beads (Invitrogen) were pre-equilibrated in BC buffer containing 300 mM 332 KCl and 0.05% NP-40. Washes were performed on a magnetic rack. 2.5 µg of GFP antisera 333 (Abcam, ab290) for each IP was conjugated to pre-equilibrated beads by incubating for 1 hour at 334 4°C. GFP antisera conjugated beads were washed three times with BC buffer containing 300 mM 335 KCl and 0.05% NP-40 and mixed with nuclear extracts for 2 hours at 4°C. IPs were washed three 336 times with BC buffer containing 300 mM KCl and 0.05% NP-40 and resuspended in 1X SDS-337 sample buffer. Samples were heated to 95°C for 5 minutes and supernatant was loaded onto an 338 SDS 4-20% polyacrylamide gel (Biorad). Samples were either processed for mass spectrometry 339 or immunoblotting. 340 341
Mass spectrometry 342
To detect proteins associated with mEGFP-CBX2 variants by mass spectrometry, co-343 immunoprecipitated material was run on an SDS polyacrylamide gel and Coomassie stained. 344
Four gel sections were excised for each immunoprecipitation. Gel sections were minced and 345 subjected to a modified in-gel trypsin digestion procedure 33 . Gel pieces were dehydrated with 346 acetonitrile and dried to completion in a SpeedVac. Gel pieces were rehydrated with 50 mM 347 ammonium bicarbonate supplemented with 12.5 ng/µl modified sequencing-grade trypsin 348 were filtered to between a 1-2% peptide false discovery rate. 360
To identify phosphorylated residues within CBX2 purified from E. coli and Sf9 cells, 361 purified protein was run on an SDS polyacrylamide gel and Coomassie stained. A band 362 corresponding to the molecular weight of tagged CBX2 was excised from the gel and analyzed 363 by mass spectrometry as above, with the following alterations. Prior to in-gel trypsin digestion, 364 minced gel pieces were reduced with 1 mM DTT for 30 minutes at 60ºC followed by alkylation 365 with 5 mM iodoacetamide for 15 minutes in the dark at room temperature. During mass 366 spectrometry analysis, a modification of 79.9663 mass units to serine, threonine, and tyrosine 367 was included in the database searches to determine phosphopeptides. Phosphorylation 368 assignments were determined by the Ascore algorithm 36 . 369 370 Immunofluorescence 371
Fixed cells on coverslips were washed once with PBS, then permeabilized in PBS with 0.2% 372 Triton X-100 for 15 minutes. After permeabilization, cells on the coverslip were blocked for 30 373 minutes with incubation solution (PBS with 3% BSA, 0.05% Triton X-100). Coverslips were 374 then incubated with incubation solution containing primary antibodies (anti-RING1b (Bethyl, 375 A302-869A, 1:4500) or anti-RING1b (Abcam, ab3832, 1:900)) overnight at 4°C in the dark to 376 minimize bleaching of GFP fluorescence. Coverslips were washed three times with PBS with 377 0.1% Tween-20, then incubated with incubation solution containing secondary antibodies 378 (Alexa-568 conjugated anti-rabbit, or Cy3 conjugated anti-goat, both 1:500) for two hours in the 379 dark. After three washes with PBS containing 0.1% Tween-20, coverslips were rinsed with 380 distilled water and mounted on slides with mounting medium containing DAPI. All incubations 381 and washes were done at room temperature except incubation with primary antibody. Slides were 382 imaged with a Nikon 90i Eclipse microscope as described above. 383 384 Fluorescence recovery after photobleaching (FRAP) 385 FRAP was performed on a Nikon A1R laser-scanning confocal inverted microscope as described 386 above for live cell imaging of 3T3 fibroblasts transduced with mEGFP-CBX2 and induced with 387 500 ng/mL of doxycycline. Images were acquired every 2 seconds for 90 seconds (45 frames). 388
The first five frames were collected before the bleach pulse for baseline fluorescence. A circular 389 region of interest (ROI) with a radius of 0.5-1 µm was selected for bleaching puncta with 100% laser power (488 nm). Fluorescent intensities and images analysis was done using Fiji software. 391 FRAP curves were generated as previously described 22 using three step normalization. First, the 392 mean intensity of the bleach spot and the whole nucleus at each time point was normalized to the 393 respective pre-bleach baseline intensity. Second, the relative bleach spot intensity was 394 normalized to the relative nuclear intensity. Finally, the difference between the double-395 normalized FRAP intensity before and at the first frame after bleach pulse was calculated and 396 normalized to 100%. FRAP recovery measurements were averaged over 15 replicates spanning 397 multiple cells. Immobile fraction was estimated as percent fluorescence intensity unrecovered at 398 last frame. 399 400
Hexanediol treatments 401
Live cell imaging was performed as described above for 3T3 fibroblasts transduced with 402 mEGFP-CBX2 and induced with 500 ng/mL of doxycycline. Images were acquired every 8 403 seconds for 600 seconds (75 frames). After 1 minute and as image acquisition was ongoing, 1,6-404 hexanediol diluted in media was added to a final concentration of 10%. In control experiments, 405 an equal volume of media alone is added. The time of 1,6-hexanediol addition is time 0" and the 406 first frame after addition is time 16". Image analysis was done using Fiji. 407 408
Preparation of Cy5-labeled ligands and incorporation into condensates 409
For visualization of DNA incorporation into condensates, the G5E4 nucleosome-positioning 410 array 23 was labeled with Cy5. The G5E4 array was excised from pG5E4 by restriction digest 411 with Asp718, ClaI, DdeI and DraIII and purified by PEG precipitation. The excised fragment was end labeled using Klenow Fragment (New England Biolabs) to incorporate Cy5-dCTP into 413 the G5E4 array. 414
For visualization of RNA incorporation into condensates, templates for in vitro 415 transcription of CAT7 RNA 25 were generated. The DNA sequence encoding CAT7 was 416 amplified from human genomic DNA using primers incorporating a T7 promoter and 417 subsequently cloned into pUC19. DNA templates for in vitro transcription were prepared by 418 SmaI digest of the pUC19 vector containing T7-CAT7, followed by ethanol precipitation. In 419 vitro transcription was performed with the MEGAscript T7 kit (Ambion), incorporating trace 420
Cy5-UTP into the reaction. In vitro transcription proceeded for 4 hours at 37ºC, followed by 421 digestion of template DNA with DNase I for 30 minutes at 37ºC. RNA was purified using a 422
MEGAclear kit (Ambion). 423
For visualization of polynucleosome and MLA polynucleosome incorporation into 424 condensates, HeLa nucleosomes were isolated as previously described 37 and MLA nucleosomes 425 containing an H3K27me3 analog were assembled as described 24 . HeLa and MLA nucleosomes 426 were assembled onto Cy5-labeled G5E4 nucleosome-positioning arrays by salt dialysis as 427 previously described 38 . Proper assembly of polynucleosome arrays was confirmed by EcoRI 428 digest to visualize mononucleosomes and HhaI digest to assess the extent of occupancy of the 429 central core of the array lacking nucleosome positioning sequences. 430
To assess incorporation of Cy5-labeled ligands into in vitro protein condensates, purified 431 mEGFP fusion proteins were diluted into buffer as described above. Cy5-labeled ligands were 432 added to pre-formed condensates to a final concentration of 0.3 µM. Contemporaneous 433 incorporation of ligands into condensates was assessed by adding Cy5-labeled ligands to purified 434 mEGFP fusion proteins prior to condensate formation. In vitro condensates were visualized by 435 fluorescence microscopy as described above. 436 437 Analysis of protein disorder and charge 438
Predicted protein disorder for CBX2 was calculated using the PONDR VSL2 algorithm 39 . 439
Protein charge distribution was calculated for CBX2 variants using the EMBOSS charge 440 algorithm 40 with default parameters using a window size of 10 residues. 441 442
Immunoblot analysis 443
The indicated cell lines were induced with the specified concentration of doxycycline for 24 444 hours, cells were lysed in RIPA buffer (Thermo Fisher Scientific, 89900), and protein was 445 quantified by Bradford assay. Samples were run on SDS 4-20% polyacrylamide gels (Biorad) 446 and transferred to nitrocellulose membranes. After transfer, membranes were blocked with 5% 447 milk in TBS with 0.1% Tween-20 for 1 hour at room temperature. Membranes were incubated 448 with anti-CBX2 (Santa Cruz, sc19297, 1:500) or anti-GAPDH (Santa Cruz, sc32233, 1:2500) 449 diluted in 2% milk in TBS with 0.1% Tween-20 overnight at 4°C. After washing three times 450 with TBS with 0.1% Tween-20 for 5 minutes at room temperature, membranes were incubated 451 with secondary antibody conjugated to HRP (1:20,000) diluted in 1% milk in TBS with 0.1% 452 Tween-20 for 1 hour at room temperature. Membranes were washed three times with TBS with 453 0.1% Tween-20 for 5 minutes at room temperature and developed with SuperSignal West Pico 454 PLUS Chemiluminescent Subtrate (Thermo Fisher Scientific, 34577) and imaged using a 455 Chemidoc (Biorad) or film. Quantification was done using Fiji software and relative expression 456 level was normalized to 1 for CBX2 at each doxycycline concentration. For analysis of proteins 457 obtained by co-IP, membrane was incubated with anti-GFP-HRP (Abcam, ab184207, 1:10,000), 458 anti-CBX2 (Santa Cruz, sc19297, 1:500), anti-RING1b (Bethyl, A302-869A, 1:5,000), or anti-459 PHC1 (Active Motif, 39723, 1:1,000) and processed as above (note the secondary antibody step 460 was omitted for anti-GFP-HRP blotted membranes). All co-IP membranes were imaged using a 461 Chemidoc (Biorad). To compare expression of different CBX paralogs, CJ7 mESCs and E11.5 462 Cbx2 +/+ , Cbx2 +/-, and Cbx2 -/mouse embryos were examined in comparison to 3T3 fibroblasts. For each experiment a representative micrograph from two independent protein preparations is 596
shown. e, Micrographs of mEGFP-CBX2 + RING1b at indicated µM protein concentration. 597
Scale bars = 10 µm. to visualize separation of high concentration condensates at increasing protein concentration. c, 604
Micrographs of mEGFP-tagged CBX2 mutants and CBX7 + RING1b heterodimers, and full 605 PRC1 complexes all at 6.3 µM. For each experiment a representative micrograph from two 606 independent protein preparations is shown. d, Micrographs of mEGFP-CBX2DCbox alone 607 (unphosphorylated) (12.5 µM) or from cells co-expressing catalytic subunits of casein kinase II 608 (CK2) (phosphorylated) (12.5 µM). e, Micrographs of salt-dependent reversibility assay. 609
Phosphorylated mEGFP-CBX2DCbox (12.5 µM) in buffer containing 100 mM KCl, followed by 610 buffer containing 500 mM KCl and then diluted back to 100 mM KCl. Scale bars = 10 µm. 
